233 event(s) found
Confiance et Démocratie en Santé en Cancérologie
Cette journée d’étude, co-organisée par les 5 SiRICs franciliens et le Cancéropôle IDF, s’intéressera à la thématique de La Confiance en lien avec la démocratie en santé, notamment dans le domaine du cancer. Elle vise à réunir les multiples acteur.trice.s du champ de la santé et notamment de la cancérologie : chercheur·ses issu·es de différentes disciplines, patient.e.s, professionnel.le.s de santé, pour échanger sur le sujet complexe et multidimensionnel de La Confiance à l’aune des disciplines représentées, et faire émerger collectivement des pistes potentielles de recherches ou d’actions.
SIR 2026 Annual Scientific Meeting
Join us in Toronto for the SIR 2026 Annual Scientific Meeting, where the global IR community will come together to share the latest research and spark innovation. This year’s theme is 'Creating communities. Transforming care.' This reflects our commitment to fostering collaboration across every corner of the specialty, whether you're a trainee, seasoned physician, researcher or industry leader. Expect a dynamic program filled with cutting-edge science, practical education, hands-on learning, and countless opportunities to engage with peers and thought leaders from around the world. Visit the meeting website for the latest updates, full program details and registration information.
3rd Pediatric Exercise Oncology Congress – PEOC meets FORTEe
Join leading clinicians, researchers, and stakeholders for two dynamic days focused on the future of exercise in pediatric oncology. Hear cutting-edge keynotes from David Mizrahi (Australia), Carmen Fiuza-Luces (Spain), Keri Schadler (USA), Martin Kaj Fridh (Denmark) and Precious Madzimbe (Zimbabwe) Present your latest findings through oral talks, rapid presentations, or interactive posters Connect with peers at our Congress Dinner and FORTE Science Evening Whether you’re an exercise professional, clinician, researcher, student, or patient advocate – PEOC × FORTE will inspire and equip you to integrate exercise into pediatric oncology care and research.
30th Acute Leukemia Forum
Celebrating its 30th year, the Acute Leukemia Forum (ALF) continues its tradition of being a premier event for hematology and oncology professionals. This milestone conference brings together leading experts to share groundbreaking research and clinical advances that shape the treatment and management of acute leukemia and myelodysplastic syndromes. As we look ahead to 2026, ALF will focus on addressing the evolving educational needs of those involved in the care of patients with these challenging malignancies.
AACR Oncology Industry Partnering Event: From Cancer Discoveries to Patients
This annual event provides a unique networking experience for attendees to learn from our industry partners who will highlight the oncology pipelines and platforms of leading pharmaceutical and biotechnology companies as well as emerging scientific themes across the biopharmaceutical industry. This oncology-focused event will once again feature thought-leaders who will share their innovation strategies for drug development and present analysts and investors new partnership and licensing opportunities to advance these concepts.
ESMO Summit Latin America 2026
The ESMO Summit Latin America 2025 is a two-day educational event with presentations focused on several key disease sites. Created for oncology professionals in Latin America by international and local key opinion leaders, the Summit will put into context the most significant treatment advances presented at the ESMO annual Congress. Summit Objectives: to provide the oncology community with a summary of the most significant treatment advances presented at the ESMO Congresses; to review the current standard of care for key malignancies from a local and international perspective; and to discuss the current controversies in the management of specific cancers Target Audience: Medical and clinical oncologists, pharmacists, nurses, students, fellows, residents, general practitioners in oncology and other oncology healthcare professionals.
3er Workshop INFECTHEMA
In Spanish: "Estamos encantados de invitaros a la 3a edición del workshop de Infecciones en Hematología INFECTHEMA, que tendrá lugar en Valencia los próximos días 16 y 17 de abril en el edificio Veles e Vents."
AACR Annual Meeting 2026
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world. More information about the AACR Annual Meeting 2026 will be available online and in the Call for Abstracts in late August 2025.
Texas Blood Cancer Conference
Blood Cancer United Blood Cancer Conferences are free education events for blood cancer patients, survivors, caregivers, family members and healthcare professionals to learn more about treatment options, emerging therapies, management of survivorship issues and Blood Cancer United resources.
APS 2026
APS 2026 organized by APS
World Indigenous Cancer Conference 2026
World Indigenous Cancer Conference 2026 organized by Hei Āhuru Mōwai Maori Cancer Leadership Aotearoa
Innovations in Translational Models: Replacing In Vivo Models With Complex Cellular Systems
More information coming soon…
11th Translational Research Conference: Myeloproliferative Neoplasms
ESH Translational Research Conferences focus on leading-edge basic, clinical and therapeutic research and future perspectives. The presentation of unpublished data is encouraged. Ample time is deliberately provided for in-depth scientific discussion and interaction. Registered participants further benefit from a variety of opportunities for informal scientific interaction with the world’s leading experts in their field, including during small Meet the Expert sessions and Mentored Posters Walks. New insights into the molecular pathogenesis, classification, and management of patients with Myeloproliferative Neoplasms (MPN) have arisen at increasing pace during the past years. This International Conference brings together scientists and clinicians to present and discuss new data on the cellular and molecular biology of these disorders as well as their diagnosis and treatment.
2026 ASPHO Conference
The leading conference for pediatric hematology/oncology subspecialists awaits you next spring at the 2026 ASPHO Conference! Don't miss the premier conference for subspecialty education, networking, and inspiration at the 2026 ASPHO Conference in Minneapolis, MN, April 29-May 2, 2026.
International Prostate Cancer Symposium (IPCS)
The International Prostate Cancer Symposium (IPCS) is a specialized event that takes place in the days leading up to the Advanced Prostate Cancer Consensus Conference (APCCC). It serves as a focused meeting point where experts, researchers, clinical specialists, and industry representatives gather to delve deeper into specific topics related to next-generation treatment modalities poised to transform prostate cancer care and shape future consensus treatment guidelines. With participants from major academic centers and pharmaceutical companies, IPCS serves as a dynamic platform for cross-sector dialogue, knowledge exchange, and strategic networking. Designed to foster new collaborations and accelerate translational impact, IPCS is a unique opportunity to connect with global thought leaders shaping the future of prostate cancer research and treatment. AACR is pleased to support the IPCS, and the opening lecture from AACR Past President Charles L. Sawyers, MD, FAACR.
2nd EHA-SWG Scientific Meeting on MDS/MPN/AML : Commonalities and Differences of Myeloid Neoplasms
This comprehensive 2.5-day event builds on the success of the inaugural EHA-SWG Scientific Meeting on MDS/MPN/AML, held in November 2023, which has proven to be a pivotal platform for identifying key similarities and differences between Myelodysplastic Neoplasms (MDS), Myeloproliferative Neoplasms (MPN), and Acute Myeloid Leukemia (AML). It aims to delve deeply into basic and translational science, while also exploring the most recent advances in science and clinical care for these diseases. Representing a unique opportunity to convene experts in these three distinct yet overlapping areas, the event is targeted at various levels, from experienced hematologists to junior trainees.
Rocky Mountain Blood Cancer Conference
Blood Cancer United Blood Cancer Conferences are free education events for blood cancer patients, survivors, caregivers, family members and healthcare professionals to learn more about treatment options, emerging therapies, management of survivorship issues and Blood Cancer United resources.
Myeloma Week 2026 - Understanding Myeloma: From Diagnosis to Treatment Foundations
In this webcast, we break down what myeloma is, how it develops, and the key signs and symptoms that often lead to diagnosis. We’ll explain the current understanding of risk factors, how the disease behaves in the body, and the tools clinicians use to monitor and assess its progression. Participants will also learn about today’s treatment landscape, including first-line therapies and emerging drug classes that are shaping the future of myeloma care.
ESAC Inaugural Meeting: Artificial Intelligence for Oncology
One year after the official launch of the European Interdisciplinary Society for AI in Cancer Research, a cross-disciplines community dedicated to advancing the thoughtful, ethical, and impactful integration of AI into cancer research and care, we are thrilled to share our next major milestone: ESAC’s inaugural Annual Meeting, hosted by Politecnico di Milano and co-organized with Fondazione IRCCS Istituto Nazionale dei Tumori di Milano.
ESMO Breast Cancer 2026
Join the global breast cancer community in Berlin, Germany, from 6 to 8 May 2026 or online for a specialised event dedicated to advancing the care and treatment of patients worldwide. This international congress will bring together leading experts, researchers, and clinicians to examine the latest breakthroughs in breast cancer across the entire care continuum—from early detection to treatment innovations and long-term survivorship. Explore the most up-to-date science in breast cancer diagnosis and treatment strategies, collaborate with global experts to share real-world experiences and help us build the future of breast cancer care.
2nd Symposium : AI for Clinical and Translational Medicine
Building on the success of our inaugural event, this year’s symposium brings together an exceptional lineup of international speakers, cutting‑edge research presentations, and engaging interactive sessions. Throughout the day, we will spotlight the latest breakthroughs in AI and their transformative impact on clinical and translational medicine. From predictive analytics and personalized treatment strategies to AI‑powered diagnostics and decision‑support systems, the program will showcase how data‑driven innovations are reshaping the future of healthcare.
Advances in Cell-based Screening
The pharmaceutical industry is poised for a paradigm shift: moving away from animal models prior to human trials. This conference unites leaders from pharma, academia, and the exhibitor ecosystem to address the critical question: What is needed to engineer the post-animal drug discovery pipeline? Achieving this future requires fundamental changes – testing compounds earlier in more relevant cells, at significantly larger scales, to generate the comprehensive foundational data necessary to reduce animal dependency.
Myeloma Week 2026 - Myeloma Management: Navigating Side Effects and Long-Term Care
Myeloma Management: Navigating Side Effects and Long-Term Care provides a clear, practical overview of myeloma, explaining what the disease is, how it is diagnosed, and why each person’s experience can differ. This webcast will walk participants through today’s treatment options—from initial therapies to newer and more advanced approaches now available. The session highlights what patients can typically expect at each stage of treatment, including how decisions are made and how care is tailored to individual needs. The presentation will also address common side effects, how they are managed, and what long-term care and monitoring can look like as myeloma often becomes a chronic condition. Attendees will leave with a better understanding of the treatment journey, the range of experiences patients may encounter, and the key questions to consider when navigating myeloma care.
MEET2WIN - 11th Edition
Every year, the MEET2WIN convention brings together some 300 European players specifically involved in translational research and innovation in oncology in the broadest sense (researchers, clinicians, entrepreneurs, biotechs, pharmaceutical groups, investors, support structures, etc.) keen to expand their network of contacts and optimize their collaborations in the fight against cancer.